A Chimeric HIV-1 gp120 Fused with Vaccinia Virus 14K (A27) Protein as an HIV Immunogen.
In the HIV vaccine field, there is a need to produce highly immunogenic forms of the Env protein with the capacity to trigger broad B and T-cell responses. Here, we report the generation and characterization of a chimeric HIV-1 gp120 protein (termed gp120-14K) by fusing gp120 from clade B with the v...
Main Authors: | Aneesh Vijayan, Juan García-Arriaza, Suresh C Raman, José Javier Conesa, Francisco Javier Chichón, César Santiago, Carlos Óscar S Sorzano, José L Carrascosa, Mariano Esteban |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4514760?pdf=render |
Similar Items
-
DNA Vaccines Against HIV-1: Augmenting Immunogenicity of gp120
by: Farfan Arribas, Diego Jose
Published: (2002) -
Glycoform and net charge heterogeneity in gp120 immunogens used in HIV vaccine trials.
by: Bin Yu, et al.
Published: (2012-01-01) -
Immunogenicity of the outer domain of a HIV-1 clade C gp120
by: Xu Xiaodong, et al.
Published: (2007-05-01) -
Enhanced immunogenicity of HIV-1 envelope gp140 proteins fused to APRIL.
by: Gözde Isik, et al.
Published: (2014-01-01) -
gp120 Immunogen Design And Characterization
by: Chakraborty, Kausik
Published: (2011)